Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
5dB2PwWpxJFSeYsV
